Wen Zhang

12.0k total citations · 1 hit paper
210 papers, 7.3k citations indexed

About

Wen Zhang is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Wen Zhang has authored 210 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Molecular Biology, 31 papers in Cancer Research and 21 papers in Genetics. Recurrent topics in Wen Zhang's work include MicroRNA in disease regulation (17 papers), Epigenetics and DNA Methylation (17 papers) and Cancer-related gene regulation (14 papers). Wen Zhang is often cited by papers focused on MicroRNA in disease regulation (17 papers), Epigenetics and DNA Methylation (17 papers) and Cancer-related gene regulation (14 papers). Wen Zhang collaborates with scholars based in China, United States and Canada. Wen Zhang's co-authors include Timothy R. Hughes, Quaid Morris, Benjamin J. Blencowe, Paul M. Evans, Tomas Babak, Kyunghee Choi, Chunming Liu, Yilin Cao, Bo Tang and Ping Li and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Wen Zhang

190 papers receiving 7.2k citations

Hit Papers

Selective chemical labeling reveals the genome-wide distr... 2010 2026 2015 2020 2010 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wen Zhang China 42 5.1k 1.0k 740 524 501 210 7.3k
Jinsong Li China 44 5.8k 1.1× 852 0.8× 1.3k 1.8× 414 0.8× 259 0.5× 299 8.8k
Liang Zhang China 44 4.4k 0.9× 1.1k 1.1× 758 1.0× 511 1.0× 759 1.5× 218 7.2k
Yiwen Chen United States 43 5.5k 1.1× 1.8k 1.7× 596 0.8× 288 0.5× 520 1.0× 134 6.9k
Wei Ge China 40 4.5k 0.9× 1.6k 1.5× 610 0.8× 690 1.3× 226 0.5× 169 7.5k
Yong Zhao China 47 7.2k 1.4× 2.7k 2.6× 594 0.8× 248 0.5× 610 1.2× 198 9.7k
Yunlong Liu United States 49 6.1k 1.2× 2.3k 2.2× 889 1.2× 353 0.7× 402 0.8× 366 9.6k
Ling Cai United States 43 4.9k 1.0× 1.6k 1.6× 552 0.7× 479 0.9× 212 0.4× 194 8.4k
Ping Chen China 46 4.8k 0.9× 427 0.4× 716 1.0× 332 0.6× 640 1.3× 237 7.5k
Vincent L. Cryns United States 51 5.7k 1.1× 898 0.9× 589 0.8× 585 1.1× 1.2k 2.3× 106 9.1k
Lincoln V. Johnson United States 51 7.1k 1.4× 448 0.4× 563 0.8× 477 0.9× 772 1.5× 89 12.4k

Countries citing papers authored by Wen Zhang

Since Specialization
Citations

This map shows the geographic impact of Wen Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Zhang more than expected).

Fields of papers citing papers by Wen Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Zhang. The network helps show where Wen Zhang may publish in the future.

Co-authorship network of co-authors of Wen Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Zhang. A scholar is included among the top collaborators of Wen Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Zhang. Wen Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhao, Yinghong, Wen Zhang, Xin Li, et al.. (2025). pNaktide reverses metabolic reprogramming and disease progression of ATP1A1-deficiency clear cell renal cell carcinoma. Cancer Gene Therapy. 32(12). 1385–1399. 1 indexed citations
3.
Song, Yongchen, et al.. (2025). Sustainable Transport Appraisal: A Literature Review and Implications for Policy Makers. 627–632. 1 indexed citations
4.
Yu, J., Jiaqi Su, Wen Zhang, et al.. (2025). Mitigating effects of plasmalogens on age-related cognitive impairment. Journal of Functional Foods. 128. 106790–106790.
5.
Wang, Yuqian, et al.. (2024). LPCAT1 promotes melanoma cell proliferation via Akt signaling. Oncology Reports. 51(5). 4 indexed citations
7.
Chen, Zhuo, Rongsheng Zhang, Xinfeng Zhang, et al.. (2024). Structure-CLIP: Towards Scene Graph Knowledge to Enhance Multi-Modal Structured Representations. Proceedings of the AAAI Conference on Artificial Intelligence. 38(3). 2417–2425. 8 indexed citations
8.
Hou, Xiaoyue, Mengjiao Li, Wen Zhang, et al.. (2024). Domain III β4–β5 Loop and β14–β15 Loop of Bacillus thuringiensis Vip3Aa Are Involved in Receptor Binding and Toxicity. Toxins. 16(1). 23–23. 3 indexed citations
9.
Liu, Ruiqi, Wen Zhang, Min Liu, et al.. (2023). BMI1 fine-tunes gene repression and activation to safeguard undifferentiated spermatogonia fate. Frontiers in Cell and Developmental Biology. 11. 1146849–1146849. 7 indexed citations
10.
Wang, Run, Ningning Kang, Wen Zhang, et al.. (2023). The developmental toxicity of PM2.5 on the early stages of fetal lung with human lung bud tip progenitor organoids. Environmental Pollution. 330. 121764–121764. 26 indexed citations
11.
Zhang, Wen, et al.. (2023). Downregulation of circAsxl2 Relieves Neuronal Injury Induced by oxygen-glucose deprivation/reperfusion. Molecular Neurobiology. 61(2). 812–820. 4 indexed citations
12.
Liu, Min, Cheng Zhang, Chunxia Yang, et al.. (2021). NudC L279P Mutation Destabilizes Filamin A by Inhibiting the Hsp90 Chaperoning Pathway and Suppresses Cell Migration. Frontiers in Cell and Developmental Biology. 9. 671233–671233. 3 indexed citations
13.
Liu, Xian, Wen Zhang, Mengnan Wang, et al.. (2021). TSMiner: a novel framework for generating time-specific gene regulatory networks from time-series expression profiles. Nucleic Acids Research. 49(18). e108–e108. 5 indexed citations
14.
Tong, Jiefei, Jonathan R. Krieger, Paul Taylor, et al.. (2020). Cancer proteome and metabolite changes linked to SHMT2. PLoS ONE. 15(9). e0237981–e0237981. 15 indexed citations
15.
Fu, Wei, Shujun Wang, Guang Zhou, et al.. (2011). Residual Undifferentiated Cells During Differentiation of Induced Pluripotent Stem Cells In Vitro and In Vivo. Stem Cells and Development. 21(4). 521–529. 38 indexed citations
17.
Finney, Lydia, Suneeta Mandava, Lyann M. B. Ursos, et al.. (2007). X-ray fluorescence microscopy reveals large-scale relocalization and extracellular translocation of cellular copper during angiogenesis. Proceedings of the National Academy of Sciences. 104(7). 2247–2252. 169 indexed citations
18.
Zhang, Wen, Wei Liu, Lei Cui, & Yilin Cao. (2007). Tissue engineering of blood vessel. Journal of Cellular and Molecular Medicine. 11(5). 945–957. 166 indexed citations
19.
Zhang, Wen, Xi Chen, Yoichi Kato, et al.. (2006). Novel Cross Talk of Krüppel-Like Factor 4 and β-Catenin Regulates Normal Intestinal Homeostasis and Tumor Repression. Molecular and Cellular Biology. 26(6). 2055–2064. 120 indexed citations
20.
Ema, Masatsugu, Patrick W. Faloon, Wen Zhang, et al.. (2003). Combinatorial effects ofFlk1andTal1on vascular and hematopoietic development in the mouse. Genes & Development. 17(3). 380–393. 200 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026